Current opinion in HIV and AIDS 2017 08 10() doi 10.1097/COH.0000000000000407
PURPOSE OF REVIEW
There is a strong link between HIV, smoking and illicit drugs. This association could be clinically relevant as it may potentiate the risk of cardiovascular diseases (CVD). The purpose of this review is to bring readers up-to-date on issues concerning the cardiovascular risk associated with tobacco and illicit drugs in patients living with HIV (PLHIV), examinating the studies related to this topic published in the last year.
There is a strong association between smoking and atherosclerotic disease in PLHIV, reducing life expectancy secondary to CVD by up to 6 years. Illicit drugs were associated with increased risk of atherosclerotic problems but in lesser extent than smoking. It has been demonstrated a significant association of drugs such as cocaine with subclinical coronary atherosclerosis. The relation among marijuana, heroin and amphetamines with atherosclerosis generate more controversy. However, those drugs are associated with cardiovascular morbidity, independently of smoking and other traditional risk factors.
Tobacco and illicit drugs are linked to CVD in HIV patients. This leads to the need to create special programs to address the addiction to smoking and illicit drugs, in order to mitigate their consequences and reduce cardiovascular risk.